US investors hit panic button while Trump marches to the beat of his own drum

Published 01-FEB-2017 12:07 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

A two-hour rally at the end of the day restored some respectability to the Dow’s performance after it had fallen nearly 200 points from the previous day’s close of 19,971 points to hit a low of 19,785 points.

The close of 19,864 points represented a decline of 0.5%. The NASDAQ fared better, but the close of 5,614 points only represented a marginal increase on the previous day.

It should be noted that historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering stocks in these markets should seek independent financial advice.

US markets are still lacking confidence, triggered by political instability and a mixed earnings season.

The Fed Reserve’s interest rate policy meeting this week is likely to be more of a reading between the lines exercise rather than debate over whether or not interest rates will move. Most analysts are tipping rates to stay on hold.

While Fed Chairwoman, Janet Yellen, won’t be drawn on political issues, part of her charter is to factor in both domestic and global volatility when framing monetary policy. Consequently, the events of recent weeks, the sharp uptick in investor anxiety and the potential for further volatility will be issues central to decision-making over coming months.

It is worth remembering that on a number of occasions in 2016 Yellen referred to issues such as Brexit and volatility in Asian markets to keep rates on hold when domestic data was looking more positive.

Consequently, it will be difficult for Yellen to ignore the extremely fragile and uncertain political and economic conditions in the US.

All European markets trended lower with the FTSE 100 (-0.3%) responding negatively to an appreciation in the British pound, a factor that can impact the earnings of British-based companies that generate overseas income.

The DAX and the Paris CAC 40 were down 1.2% and 0.7% respectively.

The oil price pulled back sharply late in trading but still closed some 0.4% higher.

Gold was the big mover as its safe haven status saw it increase from the previous day’s close of US$1,196 per ounce to a high of US$1,217 per ounce before closing at $1,212 per ounce, representing an increase of 1.4%.

On the base metals front, zinc continues to notch up long-term highs and last night rallied more than 3% to hit the US$1.30 per pound mark. While lead has been tracking zinc’s strong run closely, it came off slightly to finish at US$1.07 per pound.

Nickel and copper both gained ground with the latter breaking through the psychological US$2.70 per pound level.

The Australian dollar went close to touching US$0.760 in early trading, but is now hovering in the vicinity of US$0.758.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free